We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

100 hedge funds and large institutions have $64M invested in Sanofi Contingent Value Rights in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $57.4M → $64M (+$6.63M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less funds holding

Funds holding: 105 → 100 (-5)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
100
Holders Change
-5
Holders Change %
-4.76%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
8
Reduced
16
Closed
16
Calls
$612K
Puts
–
Net Calls
+$612K
Net Calls Change
+$21K

Top Buyers

Rank Fund Capital Flow
1
NGA
New Generation Advisors
Massachusetts
+$241K
2
HCM
Highbridge Capital Management
New York
+$161K
3
PC
Permanens Capital
New York
+$45.5K
4
TSS
Two Sigma Securities
New York
+$10.8K
5
Goldman Sachs
Goldman Sachs
New York
+$2.59K

Top Sellers

Rank Fund Capital Flow
1
BRF
B. Riley Financial
California
-$76K
2
First Eagle Investment Management
First Eagle Investment Management
New York
-$56K
3
BMO
Beck Mack & Oliver
New York
-$50.9K
4
UOC
UBS O'Connor
Illinois
-$31.1K
5
Citadel Advisors
Citadel Advisors
Florida
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
DA
51
Dillon & Associates
Michigan
$4K – – –
Deutsche Bank
52
Deutsche Bank
Germany
$3K -$101 -250 -3%
Bank of Montreal
53
Bank of Montreal
Ontario, Canada
$3K – – –
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
$2.3K – – –
AG
55
Advisor Group
Arizona
$2K -$20 -50 -1%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$1K -$4 -10 -0.2%
CIBC Private Wealth Group
57
CIBC Private Wealth Group
Georgia
$1K – – –
US Bancorp
58
US Bancorp
Minnesota
$1K – – –
LTFS
59
Ladenburg Thalmann Financial Services
Florida
$1K +$4 +9 +0.5%
ACS
60
Archford Capital Strategies
Illinois
$1K +$274 +680 New
WEC
61
Winslow Evans & Crocker
Massachusetts
$596 – – –
SIM
62
Sonora Investment Management
Arizona
$429 – – –
SWA
63
Sutton Wealth Advisors
Florida
$142 – – –
ACA
64
Atlas Capital Advisors
Wyoming
$118 +$113 +280 New
RE
65
RBC Europe
United Kingdom
$55 – – –
ECM
66
Estabrook Capital Management
New York
$6 – – –
BRF
67
B. Riley Financial
California
– -$76K -200,046 Closed
First Eagle Investment Management
68
First Eagle Investment Management
New York
– -$56K -146,402 Closed
Citadel Advisors
69
Citadel Advisors
Florida
– -$29K -76,245 Closed
VF
70
Virtu Financial
New York
– -$9K -24,260 Closed
Bank of New York Mellon
71
Bank of New York Mellon
New York
– -$8K -19,274 Closed
CTC
72
Central Trust Company
Missouri
– -$44 -109 -5%
SWP
73
Stratos Wealth Partners
Ohio
– -$40 -100 -24%
VFA
74
Valeo Financial Advisors
Indiana
– +$2 +6 New
MOS
75
MGO One Seven
Ohio
– +$28 +69 New
1 2
3
4

GCVRZ Hedge Fund Activity: Q1 2018 in Review

100 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2018, worth a combined $64M — up 12% from $57.4M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 12 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 8 added.

The largest buyer was New Generation Advisors, adding an estimated $241K. The largest seller was B. Riley Financial, exiting entirely with an estimated $76K sold.

  • 100 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2018, down from 105 in Q4 2017.
  • Funds reported $64M of Sanofi Contingent Value Rights stock for Q1 2018, up 12% quarter-over-quarter.
  • 12 funds opened new Sanofi Contingent Value Rights positions in Q1 2018 and 16 closed out, a net change of -4 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2018 was New Generation Advisors, an estimated $241K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2018 was B. Riley Financial, an estimated $76K sold.

Based on aggregated 13F filings for Q1 2018.